Medicare Reimbursement For New Part B Drugs Lowered In Proposal

New specialty drugs will get lower interim payments from Medicare under proposed rule.

Medicare word cloud

The US Centers for Medicare and Medicaid Services has taken a step toward implementing one of the policies in the Trump Administration’s drug price reduction blueprint by proposing to lower short-term Medicare payments for certain new physician-administered drugs reimbursed under Part B.

The proposal is part of the 2019 Medicare Physician Fee Schedule update, released July 12. It would reduce payments...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers